Growing community of inventors

Hangzhou, China

Zhaokui Wan

Average Co-Inventor Count = 2.83

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Zhaokui WanXiaodong Li (7 patents)Zhaokui WanMichael Lawrence Vazquez (6 patents)Zhaokui WanMichael Lawrence Vazquez (4 patents)Zhaokui WanJian Wu (1 patent)Zhaokui WanLin Su (1 patent)Zhaokui WanJingyu Wu (1 patent)Zhaokui WanGurmit Grewal (1 patent)Zhaokui WanZhaokui Wan (10 patents)Xiaodong LiXiaodong Li (12 patents)Michael Lawrence VazquezMichael Lawrence Vazquez (6 patents)Michael Lawrence VazquezMichael Lawrence Vazquez (4 patents)Jian WuJian Wu (30 patents)Lin SuLin Su (1 patent)Jingyu WuJingyu Wu (1 patent)Gurmit GrewalGurmit Grewal (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Lynk Pharmaceuticals Co. Ltd. (10 from 10 patents)


10 patents:

1. 12421213 - Benzamides of pyrazolylamino- pyrimidinyl derivatives, and compositions and methods thereof

2. 12162866 - Crystal form of pyrazolyl-amino-pyrimidinyl derivative, and preparation method therefor and use thereof

3. 12129250 - TYK2 inhibitors and compositions and methods thereof

4. 12098142 - Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof

5. 12030870 - Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof

6. 12024503 - Benzethers and anilines of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof

7. 12024516 - Tricyclic janus kinase 1 inhibitors, and compositions and methods thereof

8. 11981663 - Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof

9. 11858933 - Tricyclic Janus kinase 1 inhibitors, and compositions and methods thereof

10. 11851431 - Tricyclic Janus kinase 1 inhibitors, and compositions and methods thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…